Skip to main content
Back to Research Library
B
Good Confidence
Randomized Controlled TrialPMC Full Text2020

The effect of low versus high fractional iron absorption on iron absorption and utilization

Stoffel NU, et alAmerican Journal of Clinical Nutrition

Key Finding

Alternate-day iron absorption 40-50% higher than consecutive day (p<0.001); 200mg alternate-day yields ~2x total absorption vs 100mg consecutive-day

Key Findings

  • 1Alternate-day absorption 40-50% higher (p<0.001)
  • 2Hepcidin elevation on consecutive days impairs absorption
  • 3200mg alternate-day = 2x absorption vs 100mg consecutive
  • 4No significant difference in GI side effects

Original title: Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women

Plain English Summary

Cross-over study in 19 women with iron-deficiency anemia found that alternate-day iron dosing increases fractional iron absorption by 40-50% compared to consecutive-day dosing due to lower hepcidin levels. Total iron absorption from 200mg alternate-day was twice that from 100mg consecutive-day.

In-Depth Analysis

Abstract

"Alternate day dosing of oral iron supplements in anemic women may be preferable because it sharply increases FIA [fractional iron absorption]."

Methods

  • Design: Cross-over study with two 6-day cycles separated by 16 days
  • Sample: 19 women with IDA (median hemoglobin 11.5 g/dL)
  • Intervention: 100 or 200 mg ferrous sulfate on days 2, 3 (consecutive), and day 5 (alternate)
  • Measurement: Erythrocyte isotope incorporation 16 days post-administration

Key Results

Fractional Iron Absorption
  • Days 2 and 5 absorption was 40-50% higher than day 3 (P<0.001)
  • Serum hepcidin significantly elevated on day 3 vs days 2 and 5 (P<0.01)
Total Iron Absorption
  • 200 mg alternate-day: approximately twice that from 100 mg consecutive-day (P<0.001)
Side Effects
  • GI side effects showed no statistically significant difference between doses (P=0.105)

Conclusions

Alternate-day administration enhances iron absorption efficiency, potentially allowing lower total doses while maintaining therapeutic benefit.

Paradigm Relevance

How this study applies to different clinical perspectives:

Standard Medical

Conventional clinical guidelines used by most doctors

Not directly relevant to this paradigm

Research Consensus

Relevant

Current scientific understanding, often ahead of guidelines

Why it matters:

Strong evidence for hepcidin-mediated absorption dynamics; replicated in subsequent studies

Metabolic Optimization

Relevant

Proactive targets for optimal health, not just disease absence

Why it matters:

Practical protocol for maximizing iron supplementation efficiency—take every other day, not daily

Study Details

Type
Randomized Controlled Trial
Methodology
Cross-over study; N=19 women with IDA (median Hb 11.5 g/dL); two 6-day cycles separated by 16 days; 100 or 200 mg ferrous sulfate with stable iron isotopes

Evidence Quality

Grade B - Cross-over study with isotope measurements. Source: PMC7193469

Topic

Related Biomarkers

FERRITINHEPCIDINHEMOGLOBIN

Calculate & Evaluate on Metabolicum

Original Source

DOI (Digital Object Identifier) is a permanent link to this publication. Unlike website URLs that can change, a DOI always resolves to the correct source.

Related Studies